FoodQualityNews.com The resistance among Campylobacter,the primary cause of foodborne diseases, from human cases was high to very high (between 30% and 50%) for ampicill...
pharmabiz.com Grifols, SA, a global healthcare company, and Aradigm Corporation, an emerging specialty pharmaceutical company, have signed an exclusive, worldwide license for Aradigm's proprietary formulations of inhaled ciprofloxacin (Pulmaquin and Lipoquin) for ... and more »
Firstpost The company acknowledged that it failed to conduct proper safety and quality tests of several drugs manufactured at the Indian plants, including generic versions of common medicines, like gabapentin , which treats epilepsy and nerve pain, and the ...
Wall Street Journal (India) They include acne drug Sotret, epilepsy and nerve pain drug gabapentin , and antibiotic ciprofloxacin. Ranbaxy's chief executive, Arun Sawhn...
Business Wire (press release) Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases. Aradigm has product ... The future results of ... and more »
